Management of muscle-invasive bladder cancer: an update
Authors:
- Mohamed A GhoneimMGMohamed A Ghoneim
- Hassan Abol-EneinHAHassan Abol-Enein
- 1 September 2008
- journal article
- review article
- Published by Springer Nature in Nature Reviews Endocrinology
- Vol. 5 (9) , 501-508
Abstract
The aim of this Review is to critically assess the currently used methods for the treatment of muscle-invasive bladder cancer. Radical cystectomy seems to be the gold standard for the treatment of bladder cancer, and the optimum extent of lymph-node dissection has now been identified. An early cystectomy should be carried out once a diagnosis of muscle invasion is established. Preoperative radiation is no longer popular, but could be due a reassessment in view of technical advances. Results of neoadjuvant and adjuvant chemotherapy trials are subject to criticism. Most trials are retrospective, used different chemotherapy protocols and did not have uniform end point assessment. Bladder-preservation strategies can offer cures for a selection of subpopulations, but these patient groups have yet to be clearly defined. Developments in molecular biology are exciting, and their potential application is pending translational research. To be meaningful and useful, future trials that involve additional or alternative modalities should be prospective, randomized and adequately powered.Keywords
This publication has 56 references indexed in Scilit:
- Effect of Preoperative Delay on Survival in Patients With Bladder Cancer Undergoing Cystectomy in Quebec: A Population Based StudyJournal of Urology, 2006
- New HIV-Drug Inhibits In Vitro Bladder Cancer Migration and InvasionEuropean Urology, 2005
- Survival after Bladder-Preservation with Brachytherapy versus Radical Cystectomy; A Single Institution ExperienceEuropean Urology, 2005
- Adjuvant Chemotherapy in Invasive Bladder Cancer: A Systematic Review and Meta-Analysis of Individual Patient DataEuropean Urology, 2005
- UPDATE ON CHEMOTHERAPY FOR ADVANCED BLADDER CANCERJournal of Urology, 2005
- SECONDARY MALIGNANT INVOLVEMENT OF GYNECOLOGIC ORGANS IN RADICAL CYSTECTOMY SPECIMENS IN WOMEN: IS IT MANDATORY TO REMOVE THESE ORGANS ROUTINELY?Journal of Urology, 2004
- Clinical and research validity of hadrontherapy with ion beamsCritical Reviews in Oncology/Hematology, 2004
- Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder CancerNew England Journal of Medicine, 2003
- CAN p53 HELP SELECT PATIENTS WITH INVASIVE BLADDER CANCER FOR BLADDER PRESERVATION?Journal of Urology, 1999
- Laparoscopic Cystectomy and Ileal Conduit: Case ReportJournal of Endourology, 1995